Brunei Darussalam vs Cape Verde: Hepatitis B surface antigen (HBsAg) prevalence
Brunei Darussalam
0.7%
in 2024
Cape Verde
0.7%
in 2024
Brunei Darussalam rank
43rd
Cape Verde rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Brunei Darussalam
- Cape Verde
How they compare
Brunei Darussalam currently reports 0.7% against 0.7% in Cape Verde, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Brunei Darussalam ahead.
Brunei Darussalam ranks 43rd and Cape Verde ranks 43rd of 194 countries.
Brunei Darussalam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 0.8% | 0.0% | Brunei Darussalam |
| 2020s | 0.8% | 0.6% | 0.2% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Brunei Darussalam or Cape Verde?
- Brunei Darussalam, at 0.7% against 0.7% in Cape Verde as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Brunei Darussalam and Cape Verde?
- 0.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Cape Verde?
- 10 years are reported by both, from 2015 to 2024.
- How do Brunei Darussalam and Cape Verde rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Brunei Darussalam ranks 43rd and Cape Verde ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.